IMSVISUAL Member Meeting – 2021

February 24, 2021
10:30am – 12:00pm PST/ 12:30pm-2:00pm CST / 1:30-3:00pm EST / 6:30-8:00pm GMT / 7:30-9:00pm GMT+1

Please join us for the IMSVISUAL Member Meeting, taking place on February 24, 2021. An agenda for the meeting will be circulated to all registrants once finalized.

If you would like to attend the IMSVISUAL Member Meeting, please register for the meeting and suggest any agenda items through this survey.

IMSVISUAL Symposium at the ACTRIMS Forum 2021

IMSVISUAL will hold a virtual symposium in conjunction with the ACTRIMS Forum 2021, which will take place virtually February 25-27, 2021. The IMSVISUAL Symposium is available to all registrants of the ACTRIMS Forum 2021

Symposium Chairs: E. Ann Yeh, The Hospital for Sick Children and Philipp Albrecht, University Hospital Düsseldorf

Six Months Results from the TONE Trial (Treatment of Optic Neuritis with Erythropoietin) in the Context of Visual Pathway Neuroprotection
Wolf Lagrèze, Universitätsklinikum Freiburg

Visual Outcome Metrics in MS: What are the Opportunities?
Heather Moss, Stanford University

Socioeconomic Disparity Correlates with Faster Inner Retinal Layer Thickness in Multiple Sclerosis
Elena Vasileiou, Johns Hopkins University School of Medicine

Identification of Optical Coherence Tomography Phenotypes and their Relationship with Patient Outcomes in Youth with Demyelinating Syndromes: Preliminary Results of an Unsupervised Machine Learning Analysis
Beyza Cifti-Kavakioglu, The Hospital for Sick Children

Neuroprotective Effects of the Sphingosine 1 Phosphate Receptor 1/5 Modulator RP-101074 on Retinal Neurodegeneration and Visual Function in Light-Induced Photoreceptor Loss
Christina Hecker, UKD

Joint IMSVISUAL-NAIMS Symposium

Thursday, February 27, 2020, 11:15 am – 1:45 pm
Palm Beach County Convention Center, Grand Ballroom

This symposium is included in your ACTRIMS Forum 2020 registration. You must be registered for the Forum to attend this symposium.

2019 ECTRIMS Meeting of IMSVISUAL

IMSVISUAL Meeting

Thursday, September 12, 2019, 17:00
Meeting Room B9, Stockholmsmässan
ECTRIMS Congress Venue

Preliminary Programme

17:00 Welcome and Proceedings
F. Paul, Berlin
17:15 Results of the OCTIMS study
F. Paul, Berlin
17:30 OCT in experimental MS models
P. Albrecht, Düsseldorf
17:45 Vision investigator race
4 brief presentations by junior researchers
TBD
18:45 Miscellaneous and Farewell
19:00 End

Snacks and beverages will be provided.


Registration

The number of participants is limited to 50 pax. Please RSVP until September 5th, 2019, by using the online registration form.

IMSVISUAL Symposium at ACTRIMS Forum 2019

It is our pleasure to invite you to our IMSVISUAL symposium at ACTRIMS Forum 2019 (being held in Dallas, Texas, February 28 – March 2), to discuss updates on vision research in multiple sclerosis and related disorders. For the third consecutive year we are fortunate to have secured ACTRIMS as our sponsor.

The symposium, integrated into the ACTRIMS program and CME accredited, will take place on Thursday, February 28th from 12:30pm – 1:45pm. Please see below the confirmed agenda for talks/speakers during the session. This symposium/session is open to all attendees of the ACTRIMS Forum 2019.

I think this will be an exciting symposium with presentations from
several groups representing existing IMSVISUAL member sites from
around the world.

We look forward to seeing you all in Dallas!

IMSVISUAL symposium at the ACTRIMS Forum 2019, Thursday, February 28th

Session Chairs: Laura Balcer, NYU Langone Health and Elena Martínez-Laspiscina, Hospital Clínic de Barcelona

Symposium Schedule

1: “Is there progressive retinal damage in neuromyelitis optica spectrum disorders?”
Friedemann Paul, NeuroCure Clinical Research Center

2: “Smartphone Suite of Visual Tests in Multiple Sclerosis”
Randy Kardon, University of Iowa Health Care

3: “Corneal Confocal Microscopy: “A rapid non-invasive technique to image neurodegeneration”
Ioannis Petropoulos, Weill Cornell Medicine – Qatar

4: “Dynamics of retinal layer atrophy in normal aging and multiple sclerosis”
Elias Sotirchos, Johns Hopkins University

5: “Retinal imaging in EAE for translational neuroprotection studies”
Philipp Albrecht, Heinrich-Heine-Universität Düsseldorf